Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pfizer’s Lipitor Extension Shot Down By Failure Of Torcetrapib Silver Bullet

Dec 11 2006

• By Daniel Poppy and Andrew Kasper

Related Content

Merck Expects Expedited Filing Of HDL-Cholesterol Drugs Using Existing Data

Dec 19 2005

Roche Builds Off Oncology Foundation With Autoimmune, Metabolic “Pillars”

Oct 02 2006

Pfizer Set For “Fundamental And Sustained” Change Under New CEO Kindler

Aug 07 2006

Pfizer Better Able To De-Risk First-In-Class Compounds, R&D Head Says

Dec 11 2006

Pfizer R&D Emphasizes M&A; Deal Structure, Integration To Be More Flexible

Dec 04 2006

Quality Not Quantity: Pfizer Cuts Sales Team To Increase Meaningful Contacts

Dec 04 2006

Pfizer Sets Sights On Becoming Top Five Biologics Player By 2010

Feb 20 2006

Pfizer Torcetrapib Phase III Program Will Cost $800 Mil.

Dec 06 2004

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window